<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0005403" disease_type="Disease or Syndrome" abbrv="">Bile reflux</z:e> has been implicated in the pathogenesis and malignant degeneration of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, but clinical studies in patients with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> arising in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> are lacking </plain></SENT>
<SENT sid="1" pm="."><plain>Ambulatory esophageal measurement of acid and <z:e sem="disease" ids="C0005403" disease_type="Disease or Syndrome" abbrv="">bile reflux</z:e> was performed with the previously validated fiberoptic <z:chebi fb="0" ids="16990">bilirubin</z:chebi> monitoring system (Bilitec) combined with a pH probe in 20 asymptomatic volunteers, 19 patients with <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) but no mucosal injury, 45 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> and erosive <z:hpo ids='HP_0100633'>esophagitis</z:hpo>, 33 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> and <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, and 14 patients with early <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> arising in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Repeat studies were done in 15 patients under medical acid suppression and 16 patients after laparoscopic Nissen fundoplication </plain></SENT>
<SENT sid="3" pm="."><plain>The mean esophageal bile exposure time showed an exponential increase from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> patients without <z:hpo ids='HP_0100633'>esophagitis</z:hpo> to those with erosive <z:hpo ids='HP_0100633'>esophagitis</z:hpo> and benign <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and was highest in patients with early <z:mp ids='MP_0002038'>carcinoma</z:mp> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (P &lt;0.01) </plain></SENT>
<SENT sid="4" pm="."><plain>Pathologic esophageal bile exposure was documented in 18 (54.5%) of 33 patients with benign <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and 11 (78.6%) of 14 patients with early <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Nissen fundoplication but not medical acid suppression resulted in complete suppression of <z:e sem="disease" ids="C0005403" disease_type="Disease or Syndrome" abbrv="">bile reflux</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0005403" disease_type="Disease or Syndrome" abbrv="">Bile reflux</z:e> into the esophagus is particularly prevalent in patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and early <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0005403" disease_type="Disease or Syndrome" abbrv="">Bile reflux</z:e> into the esophagus can be completely suppressed by Nissen fundoplication but not medical acid suppression alone </plain></SENT>
</text></document>